Overview of clinical trials for dry age-related macular degeneration
The overall goal of treating age-related macular degeneration (AMD) is to target the underlying cause of the disease and prevent, or at least slow down, the loss of vision, which requires the preservation of the choroid, retinal pigment epithelium (RPE), and photoreceptors. At present, there is no p...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Series: | Journal of Medical Sciences |
| Subjects: | |
| Online Access: | http://www.jmedscindmc.com/article.asp?issn=1011-4564;year=2017;volume=37;issue=4;spage=121;epage=129;aulast=Cheng |